Article Text
Statistics from Altmetric.com
Q In healthy postmenopausal women, what is the effect of hormone therapy (HT) on urinary incontinence (UI)?
Clinical impact ratings GP/FP/Primary care ★★★★★★★ Gynaecology ★★★★★★☆
METHODS
Design:
randomised, placebo controlled trial (Women’s Health Initiative [WHI]).
Allocation:
concealed.*
Blinding:
blinded {clinicians, participants, data collectors, outcome assessors, and monitoring committee}†.*
Follow up period:
1 year.
Setting:
40 US clinical centres.
Participants:
women who were 50–79 years of age and postmenopausal. Exclusion criteria: breast cancer, other invasive cancer in past 10 years, venous thromboembolism, hypertriglyceridaemia, or condition with poor prognosis. 16 608 women {mean age 63.3 y}† were in the oestrogen plus progestin trial, and 10 739 women (mean age 64 …